14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Tue, 7 May 2024

Trading levels for CVM

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 1.91 10.85 %
R2 1.83 6.41 %
R1 1.78 3.67 %
Current price: 1.72
Support S1 1.63 -5.22 %
S2 1.58 -7.96 %
S3 1.51 -12.40 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.05 19.19 %
R2 2.02 17.44 %
R1 1.89 9.88 %
Current price 1.72
Support S1 1.63 -5.23%
S2 1.50 -12.79%
S3 1.41 -18.02%

CVM Predictions History

2 years ago
jjsnow171.257196 predicted that CVM for 2021-09-02 is going

Rank:

2 years ago
bahatyoav.247834 predicted that CVM for 2021-07-13 is going

Rank:

3 years ago
Sven.Levon.15434 predicted that CVM for 2020-06-12 is going $13.14 (1.70%)

Rank:

4 years ago
JS predicted that CVM for 2020-05-04 is going $15.36 (11.30%)

4 years ago
Rezen Davis predicted that CVM for 2020-05-04 is going

Rank:

4 years ago
JS predicted that CVM for 2020-01-13 is going $7.88 (-15.63%)

4 years ago
2poJeff predicted that CVM for 2020-01-13 is going $7.66 (-1.54%)

4 years ago
Michael Tyler predicted that CVM for 2020-01-13 is going

4 years ago
A.J.Garcia133078 predicted that CVM for 2020-01-13 is going

Rank:

4 years ago
JS predicted that CVM for 2019-08-30 is going $7.45 (3.91%)

Click to get the best stock tips daily for free!

About CEL-SCI Corporation

CEL-SCI CEL-SCI Corporation engages in the research and development of immunotherapy for the treatment of cancer and infectious diseases. The company's lead investigational immunotherapy is Multikine, which is under phase III clinical trial for the treatment of head and neck cancer. Its Ligand Epitope Antigen Presentation System (LEAPS), a pre-clinical patented T-cell modulation process that stimulates the human immune system to fight bacterial, viral, a... CVM Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT